Literature DB >> 10516067

Scrapie pathogenesis in subclinically infected B-cell-deficient mice.

R Frigg1, M A Klein, I Hegyi, R M Zinkernagel, A Aguzzi.   

Abstract

Prion infections can present without clinical manifestations. B-cell deficiency may be a model for subclinical transmissible spongiform encephalopathy, since it protects mice from disease upon intraperitoneal administration of scrapie prions; however, a proportion of B-cell-deficient mice accumulate protease-resistant prion protein in their brains. Here, we have characterized this subclinical disease. In addition, we have studied the possibility that a neurotoxic factor secreted by B cells may contribute to pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516067      PMCID: PMC112993     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Severely combined immunodeficient (SCID) mice resist infection with bovine spongiform encephalopathy.

Authors:  K L Brown; K Stewart; M E Bruce; H Fraser
Journal:  J Gen Virol       Date:  1997-10       Impact factor: 3.891

2.  Protein conformation dictates prion strain.

Authors:  A Aguzzi
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

Review 3.  Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies.

Authors:  R T Johnson; C J Gibbs
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

4.  Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques.

Authors:  M Scott; D Foster; C Mirenda; D Serban; F Coufal; M Wälchli; M Torchia; D Groth; G Carlson; S J DeArmond; D Westaway; S B Prusiner
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

5.  Pathogenesis of scrapie in the mouse: the role of the spleen.

Authors:  H Fraser; A G Dickinson
Journal:  Nature       Date:  1970-05-02       Impact factor: 49.962

6.  A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease.

Authors:  P Brown; A Wolff; D C Gajdusek
Journal:  Neurology       Date:  1990-06       Impact factor: 9.910

7.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Prion (PrPSc)-specific epitope defined by a monoclonal antibody.

Authors:  C Korth; B Stierli; P Streit; M Moser; O Schaller; R Fischer; W Schulz-Schaeffer; H Kretzschmar; A Raeber; U Braun; F Ehrensperger; S Hornemann; R Glockshuber; R Riek; M Billeter; K Wüthrich; B Oesch
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

9.  Normal host prion protein necessary for scrapie-induced neurotoxicity.

Authors:  S Brandner; S Isenmann; A Raeber; M Fischer; A Sailer; Y Kobayashi; S Marino; C Weissmann; A Aguzzi
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

10.  Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

Authors:  M Fischer; T Rülicke; A Raeber; A Sailer; M Moser; B Oesch; S Brandner; A Aguzzi; C Weissmann
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

View more
  23 in total

1.  Neuroinvasion by a Creutzfeldt-Jakob disease agent in the absence of B cells and follicular dendritic cells.

Authors:  M J Shlomchik; K Radebold; N Duclos; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

2.  Rapid prion neuroinvasion following tongue infection.

Authors:  Jason C Bartz; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces.

Authors:  Julie Ann Edgeworth; Graham S Jackson; Anthony R Clarke; Charles Weissmann; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

4.  Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells.

Authors:  Marco Prinz; Fabio Montrasio; Michael A Klein; Petra Schwarz; Josef Priller; Bernhard Odermatt; Klaus Pfeffer; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

5.  Retrograde transport of transmissible mink encephalopathy within descending motor tracts.

Authors:  Jason C Bartz; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie.

Authors:  P Aucouturier; F Geissmann; D Damotte; G P Saborio; H C Meeker; R Kascsak; R Kascsak; R I Carp; T Wisniewski
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

7.  Progress and problems in the biology, diagnostics, and therapeutics of prion diseases.

Authors:  Adriano Aguzzi; Mathias Heikenwalder; Gino Miele
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  Subclinical prion disease induced by oral inoculation.

Authors:  Alana M Thackray; Michael A Klein; Raymond Bujdoso
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Impaired axonal transport in motor neurons correlates with clinical prion disease.

Authors:  Vladimir Ermolayev; Toni Cathomen; Julia Merk; Mike Friedrich; Wolfgang Härtig; Gregory S Harms; Michael A Klein; Eckhard Flechsig
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

10.  Recombinant prion protein induces a new transmissible prion disease in wild-type animals.

Authors:  Natallia Makarava; Gabor G Kovacs; Olga Bocharova; Regina Savtchenko; Irina Alexeeva; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  Acta Neuropathol       Date:  2010-01-06       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.